 Evolus Inc NASDAQ: EOLS has posted interim Q4 sales of approximately 34.7 million better than the consensus of 30.87 million, up 68 YY, driven by higher volumes and a higher average selling price. Total sales for FY21 are expected to be approximately 99.7 million, 76 YY. 